Anthos on Microsoft Azure is being tested with customers. Google Cloud, which continues to boost the capabilities of its hybrid and multi-cloud Anthos platform, today announced the general ...

(RTTNews) - Novartis AG (NVS), on Tuesday, announced that it has agreed to acquire privately held, clinical-stage biopharmaceutical company Anthos Therapeutics Inc. for up to $3.1 billion.

(Reuters) -Swiss pharmaceutical giant Novartis has agreed to acquire Anthos Therapeutics, a biopharma firm majority-owned by Blackstone's drug development unit, for up to $3.1 billion, to boost ...

Blackstone Life Sciences and Anthos Therapeutics, Inc. (“Anthos” or the “company”), a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the ...

Novartis has agreed to buy Anthos Therapeutics from private equity firm Blackstone for $3.1 billion, adding a drug in late-stage clinical testing to prevent complications in patients with atrial ...

Google Cloud also will disclose that Anthos on Microsoft Azure is being tested with customers and Anthos support for virtual machines is in early preview with customers. Google Cloud, which ...

Anthos Therapeutics wants to end the compromise between prescribing an effective anticoagulant and exposing patients to the risk of severe bleeding. More than 5 million people a year die of stroke ...

(Bloomberg) — Novartis AG agreed to buy US biotech Anthos Therapeutics for as much as $3.1 billion to gain a preventative stroke medicine that could be the first of its kind. The Swiss ...